Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI)-Powered Chronic Pain Coaching Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The...
-
Dublin, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The "Cannabis Market Report by Product Type, Application, Compound Type, Countries and Company Analysis, 2025-2033" report has been added to ...
-
Boston, Oct. 08, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Therapies for Rheumatoid Arthritis: Technologies and Global Markets” is projected to increase from $30.2...
-
THE WOODLANDS, Texas, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Yesterday, Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) hosted and participated in a roundtable discussion with experts to explore how to...
-
Ottawa, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The global pain management devices market size was valued at USD 7.68 billion in 2024 and is predicted to hit around USD 19.1 billion by 2034, rising at a...
-
Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Acetaminophen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's...
-
Dublin, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The "Acetaminophen Effervescent Tablets Market - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Effervescent...
-
Dublin, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The "Acetaminophen - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Acetaminophen was...
-
Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "Cancer Pain Management Market - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The Cancer Pain Management...
-
THE WOODLANDS, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the presentation of clinical data from the company’s Phase 2b PROGRESS study for...